Atossa Therapeutics (ATOS) News Today

→ Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad)

$1.35

-0.19 (-12.34%)

(As of 04/17/2024 ET)

Source

Source	Headline
	Atossa Therapeutics (NASDAQ:ATOS) Given Buy Rating at HC Wainwright americanbankingnews.com - April 17 at 4:10 AM
	5 Micro-Cap Healthcare Stocks Insiders Are Buying insidermonkey.com - April 16 at 1:24 PM
	Atossa Therapeutics (NASDAQ:ATOS) Stock Rating Reaffirmed by HC Wainwright marketbeat.com - April 16 at 11:29 AM
	Promising Synergies: Atossa Therapeutics’ Advances in ER+/HER2- Breast Cancer Treatment markets.businessinsider.com - April 15 at 8:37 PM
	Atossa Therapeutics announces breast cancer trial evaluating lead asset in combination with Eli Lilly drug proactiveinvestors.com - April 15 at 9:22 AM
	Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer globenewswire.com - April 15 at 8:30 AM
	Jonathan Finn Buys 25,000 Shares of Atossa Therapeutics, Inc. (NASDAQ:ATOS) Stock insidertrades.com - April 13 at 6:02 AM
	Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference globenewswire.com - April 11 at 8:30 AM
	Atossa Therapeutics Poised for Growth with Promising Breast Cancer Treatment markets.businessinsider.com - April 10 at 10:01 PM
	Atossa Therapeutics: Strong Buy on Promising EVANGELINE Study Results and Z-endoxifen Efficacy Potential markets.businessinsider.com - April 10 at 12:00 PM
	Atossa stock climbs 11% on breast cancer drug data msn.com - April 9 at 3:58 PM
	Atossa Therapeutics reports positive data from breast cancer treatment trial proactiveinvestors.com - April 9 at 1:02 PM
	Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen globenewswire.com - April 9 at 11:59 AM
	Q1 2024 Earnings Forecast for Atossa Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:ATOS) marketbeat.com - April 4 at 8:48 AM
	Atossa Therapeutics Inc (ATOS) Year-End Earnings: A Comprehensive Analysis finance.yahoo.com - April 3 at 7:40 AM
	Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update finanznachrichten.de - April 3 at 12:44 AM
	Optimistic Outlook for Atossa Therapeutics’ Z-endoxifen in Breast Density and Cancer Therapy markets.businessinsider.com - April 3 at 12:44 AM
	Atossa Therapeutics (NASDAQ:ATOS) Posts Earnings Results marketbeat.com - April 2 at 8:22 AM
	PSBJ taking nominations for CFO of the Year through April 5 bizjournals.com - April 2 at 4:34 AM
	ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023 msn.com - April 1 at 11:34 PM
	Atossa Therapeutics sets sights on breast cancer trial results after strong quarter of clinical milestones proactiveinvestors.com - April 1 at 4:28 PM
	Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update globenewswire.com - April 1 at 4:00 PM
	Atossa Therapeutics, Inc. (NASDAQ:ATOS) Sees Large Increase in Short Interest marketbeat.com - March 31 at 7:32 AM
	Introducing the Inno Madness Bracket bizjournals.com - March 28 at 3:36 PM
	Atossa Therapeutics' breast cancer drug milestone sparks investor enthusiasm proactiveinvestors.com - March 20 at 11:51 AM
	Atossa Therapeutics back in Nasdaq's good graces bizjournals.com - March 19 at 8:59 PM
	Atossa Therapeutics reports successful five-year treatment outcome for breast cancer patient using (Z)-endoxifen proactiveinvestors.com - March 19 at 9:16 AM
	Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient globenewswire.com - March 19 at 8:30 AM
	Atossa Therapeutics (ATOS) Set to Announce Earnings on Wednesday marketbeat.com - March 19 at 7:25 AM
	Atossa Therapeutics (NASDAQ:ATOS) Stock Rating Lowered by StockNews.com marketbeat.com - March 18 at 11:17 PM
	Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements globenewswire.com - March 18 at 8:30 AM
	ATOS Apr 2024 4.000 call finance.yahoo.com - March 16 at 9:59 AM
	Atossa Therapeutics adds breast cancer expert to board proactiveinvestors.com - March 12 at 9:53 AM
	Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors globenewswire.com - March 12 at 8:30 AM
	ATOS Oct 2024 2.000 call finance.yahoo.com - March 11 at 1:04 PM
	Atossa Therapeutics to present data from ongoing Phase 2 breast cancer trial proactiveinvestors.com - March 6 at 9:24 AM
	Atossa Therapeutics, Inc. edition.cnn.com - February 28 at 9:51 PM
	Atossa Therapeutics Stock (NASDAQ:ATOS), Short Interest Report benzinga.com - February 24 at 9:44 AM
	Atossa Therapeutics, Inc.: Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study finanznachrichten.de - February 22 at 1:10 PM
	Atossa Therapeutics doses first patient with (Z)-endoxifen in Phase 2 breast cancer trial proactiveinvestors.com - February 22 at 9:56 AM
	Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study globenewswire.com - February 22 at 8:30 AM
	Atossa Therapeutics, Inc. (YAG2.SG) au.finance.yahoo.com - February 20 at 3:57 PM
	ATOS Mar 2024 1.000 put finance.yahoo.com - February 17 at 2:26 AM
	Atossa Therapeutics, Inc. (NASDAQ:ATOS) to Post FY2023 Earnings of ($0.23) Per Share, HC Wainwright Forecasts marketbeat.com - February 14 at 7:42 AM
	Atossa spikes as H.C. Wainwright starts at Buy on lead asset msn.com - February 12 at 4:52 PM
	HC Wainwright Initiates Coverage on Atossa Therapeutics (NASDAQ:ATOS) marketbeat.com - February 12 at 8:19 AM
	Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial finance.yahoo.com - February 7 at 12:00 PM
	Atossa Therapeutics (NASDAQ:ATOS) Stock Passes Above 200-Day Moving Average of $0.81 marketbeat.com - February 6 at 3:36 AM
	Atossa Therapeutics progresses Phase II preventative breast cancer therapy msn.com - January 27 at 4:59 AM
	Traders Purchase Large Volume of Atossa Therapeutics Call Options (NASDAQ:ATOS) marketbeat.com - December 29 at 12:17 PM

Get Atossa Therapeutics News Delivered to You Automatically

Top 5 AI Stocks to Buy for 2024 (Ad)

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

ATOS Media Mentions By Week

ATOS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATOS
News Sentiment
▼
0.38

0.39
▲
Average
Medical
News Sentiment

ATOS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATOS Articles
This Week
▼
10

2
▲
ATOS Articles
Average Week

Get Atossa Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ATOS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Atossa Therapeutics (ATOS) News Today

ATOS Media Mentions By Week

ATOS Media Sentiment

ATOS News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info